Commentary

Recognizing granulosa cell ovarian tumors


 

References

2. “Rare and Uncommon Gynecological Cancers: A Clinical Guide” (Heidelberg: Springer, 2011): Reed N.

3. Obstet Gynecol. 1980 Feb;55(2):231-8.

4. “Principles and Practice of Gynecologic Oncology” (Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2013): Barakat R.

5. Indian J Surg Oncol. 2013 Mar;4(1):37-47.

6. “Uncommon Gynecologic Cancers” (Indianapolis: Wiley-Blackwell, 2014): Del Carmen M.

Dr. Gehrig is professor and director of gynecologic oncology at the University of North Carolina at Chapel Hill. Dr. Castellano is a resident physician in the obstetrics and gynecology program at the university. They reported having no relevant financial disclosures. To comment, email them at obnews@frontlinemedcom.com.

Pages

Recommended Reading

Neoadjuvant chemo for advanced ovarian cancer opens ‘window of opportunity’ for immunotherapies
MDedge ObGyn
Hormonal maintenance therapy prolonged PFS in LGSC
MDedge ObGyn
Statins improve ovarian cancer survival
MDedge ObGyn
Metformin increases efficacy of everolimus-letrozole combo for EEC
MDedge ObGyn
In-person, telephone genetic counseling yield similar outcomes
MDedge ObGyn
Study confirms role of oral contraceptives in preventing ovarian cancer
MDedge ObGyn
Study links mismatch repair defects to lower PFS in endometrial cancer
MDedge ObGyn
Oophorectomy cost-effective at 4% lifetime ovarian cancer risk
MDedge ObGyn
Including quality-of-life scores may aid decision making for patients with advanced ovarian cancer
MDedge ObGyn
Women with BRCA1 mutations at higher risk for endometrial cancers
MDedge ObGyn